89bio Statistics
Total Valuation
89bio has a market cap or net worth of $1.13 billion. The enterprise value is $536.02 million.
Important Dates
The last earnings date was Thursday, May 1, 2025, after market close.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
89bio has 145.98 million shares outstanding. The number of shares has increased by 43.38% in one year.
| Current Share Class | 145.98M |
| Shares Outstanding | 145.98M |
| Shares Change (YoY) | +43.38% |
| Shares Change (QoQ) | +26.22% |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 70.01% |
| Float | 103.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.88 |
| P/TBV Ratio | 1.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.03, with a Debt / Equity ratio of 0.06.
| Current Ratio | 18.03 |
| Quick Ratio | 16.86 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -70.83 |
Financial Efficiency
Return on equity (ROE) is -69.30% and return on invested capital (ROIC) is -42.69%.
| Return on Equity (ROE) | -69.30% |
| Return on Assets (ROA) | -39.93% |
| Return on Invested Capital (ROIC) | -42.69% |
| Return on Capital Employed (ROCE) | -62.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.16M |
| Employee Count | 93 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, 89bio has paid $732,000 in taxes.
| Income Tax | 732,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.84% in the last 52 weeks. The beta is 1.47, so 89bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -13.84% |
| 50-Day Moving Average | 7.47 |
| 200-Day Moving Average | 8.23 |
| Relative Strength Index (RSI) | 54.44 |
| Average Volume (20 Days) | 1,432,627 |
Short Selling Information
The latest short interest is 17.03 million, so 11.67% of the outstanding shares have been sold short.
| Short Interest | 17.03M |
| Short Previous Month | 15.23M |
| Short % of Shares Out | 11.67% |
| Short % of Float | 16.51% |
| Short Ratio (days to cover) | 6.90 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -403.29M |
| Pretax Income | -170.51M |
| Net Income | -386.67M |
| EBITDA | -403.25M |
| EBIT | -403.29M |
| Earnings Per Share (EPS) | -$3.30 |
Full Income StatementBalance Sheet
The company has $638.78 million in cash and $37.58 million in debt, giving a net cash position of $601.20 million or $4.12 per share.
| Cash & Cash Equivalents | 638.78M |
| Total Debt | 37.58M |
| Net Cash | 601.20M |
| Net Cash Per Share | $4.12 |
| Equity (Book Value) | 605.46M |
| Book Value Per Share | 4.15 |
| Working Capital | 645.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$399.84 million and capital expenditures -$87,000, giving a free cash flow of -$399.93 million.
| Operating Cash Flow | -399.84M |
| Capital Expenditures | -87,000 |
| Free Cash Flow | -399.93M |
| FCF Per Share | -$2.74 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |